The downgrade comes after a period of strong performance for Colgate-Palmolive, with the company reporting record-breaking sales and earnings in the recent past. However, analysts at Wells Fargo & Company believe that the company’s growth prospects are slowing down, and that the stock is becoming increasingly expensive. Here’s a breakdown of the key points:
Get Colgate-Palmolive alerts: Get Our Latest Stock Analysis on Colgate-Palmolive Colgate-Palmolive Stock Down 0.6 % Colgate-Palmolive stock opened at $105.73 on Monday. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $109.30. The stock has a market cap of $86.75 billion, a PE ratio of 33.46, a P/E/G ratio of 3.72 and a beta of 0.40. The stock’s fifty day moving average is $102.11 and its two-hundred day moving average is $95.29. Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. During the same period last year, the firm posted $0.77 EPS. The company’s revenue was up 4.9% on a year-over-year basis. On average, sell-side analysts expect that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.
This sale comes after a period of insider buying activity, suggesting a potential shift in sentiment towards the company. Insider buying and selling activity can be a valuable indicator of market sentiment. When insiders, such as executives, directors, and officers, buy or sell company stock, it can signal their confidence in the company’s future prospects.
This significant increase in holdings suggests a bullish sentiment towards the company. Institutional investors are increasingly interested in Colgate-Palmolive due to its strong brand recognition, global reach, and consistent dividend payments. These factors contribute to the institutional investors’ confidence in the company’s long-term growth potential.
Colgate-Palmolive Company Profile (Get Free Report) Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. Read More Receive News & Ratings for Colgate-Palmolive Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Colgate-Palmolive and related companies with MarketBeat.com’s FREE daily email newsletter.
news is a contributor at Roll Pet. We are committed to providing well-researched, accurate, and valuable content to our readers.
